[go: up one dir, main page]

AU4245097A - Multivalent vaccine for (clostridium botulinum) neurotoxin - Google Patents

Multivalent vaccine for (clostridium botulinum) neurotoxin

Info

Publication number
AU4245097A
AU4245097A AU42450/97A AU4245097A AU4245097A AU 4245097 A AU4245097 A AU 4245097A AU 42450/97 A AU42450/97 A AU 42450/97A AU 4245097 A AU4245097 A AU 4245097A AU 4245097 A AU4245097 A AU 4245097A
Authority
AU
Australia
Prior art keywords
neurotoxin
clostridium botulinum
multivalent vaccine
multivalent
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU42450/97A
Inventor
Bruce S Thalley
James A. Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ophidian Pharmaceuticals Inc
Original Assignee
Ophidian Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/704,159 external-priority patent/US6967088B1/en
Application filed by Ophidian Pharmaceuticals Inc filed Critical Ophidian Pharmaceuticals Inc
Publication of AU4245097A publication Critical patent/AU4245097A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1282—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU42450/97A 1996-08-28 1997-08-28 Multivalent vaccine for (clostridium botulinum) neurotoxin Abandoned AU4245097A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/704,159 US6967088B1 (en) 1995-03-16 1996-08-28 Soluble recombinant botulinum toxin proteins
US08704159 1996-08-28
PCT/US1997/015394 WO1998008540A1 (en) 1996-08-28 1997-08-28 Multivalent vaccine for clostridium botulinum neurotoxin

Publications (1)

Publication Number Publication Date
AU4245097A true AU4245097A (en) 1998-03-19

Family

ID=24828333

Family Applications (1)

Application Number Title Priority Date Filing Date
AU42450/97A Abandoned AU4245097A (en) 1996-08-28 1997-08-28 Multivalent vaccine for (clostridium botulinum) neurotoxin

Country Status (4)

Country Link
EP (1) EP1105153A4 (en)
AU (1) AU4245097A (en)
CA (1) CA2296765A1 (en)
WO (1) WO1998008540A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214787B1 (en) * 1993-09-21 2007-05-08 United States Of America As Represented By The Secretary Of The Army Recombinant vaccine against botulinum neurotoxin
US7192596B2 (en) 1996-08-23 2007-03-20 The Health Protection Agency Ipsen Limited Recombinant toxin fragments
US8012491B2 (en) 1996-08-23 2011-09-06 Syntaxin, Ltd. Recombinant toxin fragments
GB9617671D0 (en) 1996-08-23 1996-10-02 Microbiological Res Authority Recombinant toxin fragments
GB9721189D0 (en) 1997-10-08 1997-12-03 Speywood Lab The Limited Analgesic conjugates
US6495143B2 (en) 1998-07-10 2002-12-17 The United States Of America As Represented By The Secretary Of The Army Botulinum neurotoxin vaccine
AU4641299A (en) * 1998-07-22 2000-02-14 Agricultural Research Council Vaccine comprising a non-toxic immunogenic derivative of (clostridium botulinum)type d neurotoxin
GB9818548D0 (en) 1998-08-25 1998-10-21 Microbiological Res Authority Treatment of mucas hypersecretion
US20040071736A1 (en) 1998-08-25 2004-04-15 Health Protection Agency Methods and compounds for the treatment of mucus hypersecretion
GB9907429D0 (en) 1999-03-31 1999-05-26 Microbiological Res Authority Modulation of C-fibre activity
KR100876060B1 (en) 1999-08-25 2008-12-26 알러간, 인코포레이티드 Activatable Recombinant Neurotoxins
US7740868B2 (en) 1999-08-25 2010-06-22 Allergan, Inc. Activatable clostridial toxins
US20080038274A1 (en) 1999-09-23 2008-02-14 Foster Keith A Inhibition of secretion from non-neuronal cells
US7691983B2 (en) 2000-07-21 2010-04-06 Allergan, Inc. Chimera botulinum toxin type E
ATE371669T1 (en) * 2000-11-06 2007-09-15 Us Army Med Res Mat Command RECOMBINANT BOTOLINUM NEUROTOXIN LIGHT CHAIN AND FUSION PROTEINS THEREOF FOR USE IN RESEARCH AND CLINICAL THERAPY
JP3995541B2 (en) * 2002-06-28 2007-10-24 株式会社ゲン・コーポレーション Anti-chicken coccidiosis composition
US20050042775A1 (en) * 2003-08-21 2005-02-24 Nicholas Pomato Botulinum antitoxin compositions and methods
GB2456549A (en) * 2008-01-18 2009-07-22 Health Prot Agency Modified botulinum neurotoxin serotype E (BoNT/E) peptides
WO2009152452A1 (en) * 2008-06-12 2009-12-17 Huei-Hsiung Yang Fermentation method for the production of soluble botulinum neurotoxin proteins
JP6084631B2 (en) 2011-12-08 2017-02-22 ノバルティス アーゲー Clostridium difficile toxin-based vaccine
DK2854840T3 (en) * 2012-05-30 2018-03-05 Harvard College MANIPULATED BOTULINUM NEUROTOXIN
ES2895853T3 (en) 2015-03-26 2022-02-22 Harvard College Modified botulinum neurotoxin
EP3294754A4 (en) 2015-05-15 2019-04-03 Board of Regents of the University of Nebraska GENETICALLY MODIFIED CLOSTRIDIUM BOTULINUM TOXIN FOR CONDUCTING MOLECULES TO SELECTED CELLS
CN110072880B (en) 2016-08-24 2025-02-18 哈佛大学校长及研究员协会 Engineered botulinum neurotoxin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2907695A (en) * 1994-08-08 1996-03-07 Wisconsin Alumni Research Foundation Purification and pharmaceutical compositions containing type g botulinum neurotoxin
PL320214A1 (en) * 1994-10-24 1997-09-15 Ophidian Pharmaceuticals Vaccine and antitoxin for treating and preventing a disease caused by c.difficile

Also Published As

Publication number Publication date
CA2296765A1 (en) 1998-03-05
WO1998008540A1 (en) 1998-03-05
EP1105153A4 (en) 2005-01-19
EP1105153A1 (en) 2001-06-13

Similar Documents

Publication Publication Date Title
AU4245097A (en) Multivalent vaccine for (clostridium botulinum) neurotoxin
AU2103797A (en) Clostridium perfringens vaccines
AU3821497A (en) Methods for isolating nucleic acids using alkaline protease
AU6051798A (en) Method and system for injecting new code into existing application code
AU3773297A (en) Intradermal bovine polynucleotide vaccine
AU3992697A (en) Pharmaceutical preparations for intranasal administration
AU1847497A (en) Protein expression system
AU3058397A (en) Information system
AU4528496A (en) Method for generating proteolytic enzymes specific against selected peptide sequence
AU4391197A (en) Sealing system
AU8348298A (en) Split-key cryptographic system and method
HUP9801384A3 (en) Clostridium perfringens vaccine
AU4329700A (en) System and method for chromatography and electrophoresis using circular optical scanning
AU5256998A (en) Electrophoresis system
AUPO182396A0 (en) Improved nucleic acids for reducing carbohydrate epitopes
AU3746397A (en) Tempering method
AU3552797A (en) Vaccine preparations
AU4641299A (en) Vaccine comprising a non-toxic immunogenic derivative of (clostridium botulinum)type d neurotoxin
GB2327291B (en) Optical system for optical disk drive
AU2002317523A1 (en) Vaccine for Clostridium Botulinum Neurotoxin
WO1997039123A3 (en) Secreted proteins
AU7352400A (en) Improved method, system, and architecture for information display and organization
AU6636096A (en) Novel proteins within the type e botulinum neurotoxin complex
ZA976182B (en) Recombinant kynurenine-3-hydroxylase enzyme and process for its preparation.
AU4992397A (en) An improved disk drive system